Bayer Ag · XETR:BAYN

Bayer — Shareholder Meeting (March 2025)

12 slides from Bayer's shareholder meeting presentation, March 2025

  1. Slide 1: Stockholder Presentation 2025 Annual Meeting

    ///////////// Health for all, Hunger for none Stockholder Presentation 2025 Annual Meeting

  2. Slide 2: Cautionary Statements Regarding Forward-Looking Information

    Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the ac

  3. Slide 3: Update on Key Topics

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Update on Key Topics Continued progress against key strategic focus areas The Board of Management, with oversight of the Supervisory Board, is leading Bayer through a multi-year restructuring. In 2

  4. Slide 4: Advancing Our Strategic Priorities

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Advancing Our Strategic Priorities We are underway on a three-year plan to address our key priorities 2024 2025 2026 Ongoing Initiated steps to address Advance on our key key strategic priorities a

  5. Slide 5: Update on Bayer's Five Key Priorities

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Update on Bayer’s Five Key Priorities The Supervisory Board and Board of Management are working closely together to reposition the company to address the challenges we face Pharma Renewing topline,

  6. Slide 6: Capital Authorization

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Capital Authorization Bayer is requesting shareholder approval of a capital authorization; this would greatly improve our positioning as we work to resolve litigation. Bayer has not sought authoriz

  7. Slide 7: Supervisory Board Composition

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Supervisory Board Composition Supervisory Board composition aligned with Bayer’s go-forward strategy Prof. Dr. Norbert Winkeljohann Chairman Extensive global experience in management, auditing and

  8. Slide 8: Stockholder Representatives Have Skills Aligned to Our Strategy

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Stockholder Representatives Have Skills Aligned to Our Strategy Our Supervisory Board members possess a diverse range of critical skills Winkel- Achleitner Baier Cousin Goggins Mathisen Schechter S

  9. Slide 9: 2024 Board of Management Compensation

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability 2024 Board of Management Compensation New compensation system approved by shareholders in 2024; average pay outcome of 50% of target compensation aligned to performance Base Salary Fixed compensati

  10. Slide 10: Virtual Annual Meeting Authorization

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Virtual Annual Meeting Authorization Bayer is requesting shareholders approve a refresh of the 2-year virtual Annual Meeting authorization approved in 2023 Bayer has held Annual Meetings virtually

  11. Slide 11: Progress on Sustainability Targets

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability Progress on Sustainability Targets Tracking towards our concrete 2030 sustainability targets with our mission: Health for all, Hunger for none Climate Action Our impact on the We are making progres

  12. Slide 12: We Request Your Support at the 2025 Annual Stockholders' Meeting

    Business & Strategy Capital Authorization Supervisory Board BoM Compensation AGM Format Sustainability We Request Your Support at the 2025 Annual Stockholders’ Meeting Select Agenda Items Reason to Support Bayer will pay out at the legally required minimum for three years (2025 reflects the second y

Bayer — Shareholder Meeting (March 2025) on 6ix